EZEray Yihui Zhou

Eray Yihui Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eray Yihui Zhou has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Yi Zhao

    Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, China

    3 shared publications
  • Bingyu Li

    Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University , Beijing

    1 shared publication
  • Cheng Feng

    Department of Dermatology, Peking University First Hospital, Beijing, China

    1 shared publication
  • Dehua Liu

    Key Laboratory for Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing 100084, China

    1 shared publication
  • Dian Chen

    Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China

    1 shared publication
  • Fernanda H. Sakamoto

    Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA

    1 shared publication

Latest Publications

  • Aberrant B-cell and cytotoxic T-cell activation in female-pattern hair loss: A pilot comparative clinico-transcriptomic study

    by Rui Peng, Mai Shi, Yingyi Li, Jingwen Xue, Eray Yihui Zhou, Yawen Wang, Bingyu Li, Lu Peng, Yixin Gao, Jingxuan Sun, et al.


  • Cutaneous Immune Responses to Ablative Fractional Laser, Heat‐ and Cold‐Based Dermatological Procedures

    by Rikke L. Christensen, Heehwa G. Son, Eray Yihui Zhou, Uffe H. Olesen, Lilit Garibyan, William A. Farinelli, Fernanda H. Sakamoto, R. Rox Anderson, Merete Haedersdal, Shadmehr Demehri

    Objective: Physical treatment modalities, such as ablative fractional laser (AFL), electrocautery, and cryotherapy, are extensively used in the field of dermatology. This study aimed to characterize the short‐term innate and adaptive immune responses induced by AFL compared with heat‐ and cold‐based procedures.Materials and Methods: Innate (CD11b+Ly6G+ neutrophils) and adaptive (CD8+CD3+ T cells) immune cell infiltration and histopathological changes were examined in murine skin on Days 1 and 7, following AFL, monopolar‐electrocautery (RF), thermocautery, and cryotherapy. Interventions were standardized to reach the reticular dermis. Clinical skin reactions were photo‐documented daily. As a comparator, the adaptive immune response was examined in murine basal cell carcinomas (BCC) on Day 7 after AFL exposure.Results: Baseline histopathology confirmed immediate deep dermal tissue impact by all procedures. Immune cell dynamics varied across treatments throughout the progression of clinical and histopathological responses. On Day 1, AFL and heat‐based procedures triggered an innate immune response, characterized by CD11b+Ly6G+ neutrophil cell infiltration that correlated with histopathological findings and immediate onset of clinical skin reactions. In addition, heat‐based procedures led to an increase in overall dermal CD45+ cells (Day 1), which continued to rise for AFL and RF‐electrocautery at Day 7 posttreatment. On the contrary, cryotherapy did not induce immediate (Day 1) innate immune responses, but instead a delayed increase in neutrophil and CD45+ cell infiltration (Day 7), which coincided with the late onset of clinical reaction. CD3+ T cells and CD8+CD3+ T cells demonstrated a similar pattern, with an increase observed for heat‐based procedures on Day 1 and a delayed increase for cryotherapy on Day 7. Distinctive for AFL‐treated skin, the level of dermal CD3+ T cells increased over time, significant by Day 7, and AFL‐treated mouse BCCs responded with increased CD8+ T cell infiltration at Day 7 posttreatment.Conclusion: Heat‐ and cold‐based procedures developed distinct cutaneous immune responses, with cryotherapy resulting in a delayed response compared to immediate immune responses from heat‐based procedures. The substantial T cell response induced by AFL in the skin and BCC tumors indicates a potential for AFL as an adjuvant in immunotherapeutic treatments of keratinocyte cancers.


  • Epidermoid cyst removal with CO2 laser fenestration: A retrospective cohort study

    by Dehua Liu, Eray Yihui Zhou, Dian Chen, Hsiaohan Tuan, Yi Zhao

    Background Epidermoid cyst (EC) is a common and benign tumor, which can occur anywhere on the skin. Surgical excision is usually considered as the first‐line treatment. However, linear scars arising after excision for EC remain a cosmetic problem. Objective To evaluate the efficacy and safety of EC removal assisted with CO2 laser fenestration. Methods All patients diagnosed with EC and treated with CO2 laser fenestration, content extrusion, and removal of the cyst wall between January 1, 2016, and December 31, 2018, were included in this study. After a follow‐up period ranging from 6 to 27 months, scarring, recurrence, complications, and satisfaction were assessed and analyzed. Results Forty‐three of the 47 patients have been cured by a single operation. The recurrence rate was 8.5%, which was not significantly correlated with tumor sizes or locations. 46.8% of the patients had no obvious scar after treatment. No infections or complications were observed in any of these cases. 89.4% of the patients were satisfied with the effectiveness of the treatment, while 95.7% and 87.2% were satisfied with the comfort and the cosmetic results, respectively. Conclusions CO2 laser fenestration‐assisted removal procedure is effective for the treatment of ECs with good aesthetic outcome.


  • Annular Plaques With Skin Atrophy in a Young Patient

    by Eray Yihui Zhou, Yi Zhao, Zhimiao Lin

    A young woman presented with multiple arciform to annular plaques on her extremities, favoring the antecubital and popliteal fossae (Figure, A). The patient reported that these asymptomatic lesions had been present since her adolescence, and she was easily bruised with minimal trauma since birth. There was no family history of similar cutaneous findings. On close inspection, the plaques were found to be composed of individual 2- to 4-mm keratotic papules surrounding white atrophic patches. Physical examination also revealed remarkable skin atrophy on the dorsal aspects of her hands (Figure, B) and feet. The patient’s skin was generally pale and translucent with visible veins, especially on the chest and abdomen. The face appeared to be emaciated, with a pinched nose, thin lips, sunken cheeks, and prominent eyes. A punch biopsy specimen from an individual papule from the left arm was obtained and analyzed under Verhoeff–van Gieson stain (Figure, C).

  • Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients

    by Eray Yihui Zhou, Huijun Wang, Zhimiao Lin, Guiwen Xu, Zhihong Ma, Jiahui Zhao, Cheng Feng, Lina Duo, Jinghua Yin, Yong Yang

    Xeroderma pigmentosum (XP) is a rare genetic disorder which is divided into eight complementation groups: XP‐A to XP‐G and XP‐V. Some XP patients demonstrate severe cutaneous and neurological manifestations, management of which requires timely diagnosis and intervention. We performed clinical evaluation and genetic analysis on 19 patients, the largest cohort of XP to date in China. Twenty‐three mutations from six groups were identified, 16 of which were novel. All patients developed marked freckle‐like pigmentation on sun‐exposed sites while patients with XP‐A, XP‐D, XP‐F and XP‐G showed acute sunburn reactions. Only XP‐A patients displayed progressive neurological degeneration. A relatively larger proportion of XP‐A and XP‐C were found in Chinese XP patients. One XP case and two carriers were prenatally determined. This study extended the mutation spectrum of XP in China and may aid in the diagnosis and treatment of Chinese XP patients.